The DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index; 44 of the 90 sources its claims cite were checked for support.
The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science
Open accessAbstract
The proposal by the European Chemicals Agency (ECHA) to ban over 12,000 per- and polyfluoroalkyl substances (PFAS) has sparked a debate about potential consequences for the economy, industry, and the environment. Although some PFAS are known to be harmful, a blanket ban may lead to significant problems in attempting to replace PFAS-based materials for environmental transition, as well as in medical devices and everyday products. Alternative materials may potentially be less safe, as a rush to replace PFAS would reduce the time needed for toxicological analyses. Studies have shown that PFAS exhibit a diverse range of mechanisms of action, biopersistence, and bioaccumulation potential, and should thus not be treated as a single group. This is particularly true for the class of fluoropolymers. A targeted approach that considers the specific risks and benefits of each chemical may be more effective. Moreover, the proposed ban may also have unintended consequences for the environment as PFAS use is also associated with benefits such as reducing greenhouse-gas emissions and improving energy efficiency. Policymakers must carefully weigh up the potential consequences before making a final decision on the ban.
Overview
CoChat Summary
TL;DR
The paper argues that ECHA’s proposal to ban more than 12,000 PFAS as a single class is scientifically unsound because PFAS differ widely in structure, mechanisms of action, bioaccumulation, and toxicity, with fluoropolymers being a distinct low-risk class. It recommends targeted regulation of high-risk PFAS and warns of unintended consequences for medical devices, green-transition technologies, and substitution with less-characterized alternatives.
Key findings
- The proposed EU ban would affect >12,000 PFAS, but PFAS are heterogeneous; fluoropolymers have typical molecular weights >100,000 Da, and molecules >1000 Da are described as having negligible oral bioavailability, limiting bioaccumulation and toxicity.
- In vitro activation of human PPARα by tested PFAS occurred only above 10 μM—5001 ng/mL for PFOS and 4141 ng/mL for PFOA—versus reported mean serum/plasma concentrations of 7.7 and 1.9 ng/mL in Western populations.
- In airport workers exposed to contaminated groundwater, “historical” PFAS accounted for 50% of total PFAS in drinking water and 90% in serum; branched PFOS isomers had shorter half-lives than linear PFOS, with half-lives generally decreasing with decreasing chain length.
- TEF/RPF approaches for PFAS are limited by differing toxicokinetics and mechanisms; bioremediation is promising (e.g., *Acidimicrobium* sp. strain A6 defluorinating PFOA/PFOS) but challenged by PFAS structural diversity.
Methods
- Narrative commentary/review; no primary data collection, systematic search strategy, or quantitative synthesis is reported in the provided text.
- Synthesizes cited toxicological, epidemiological, and environmental studies on PFAS heterogeneity, mechanisms, bioaccumulation, TEFs, fluoropolymers, bioremediation, and substitution.
Limitations
- Stated: lack of comprehensive data on potential substitutes; limited toxicokinetic information for PFHxS, PFBS, and PFBA; more research needed to determine feasibility of bioremediation and optimize degradation of different PFAS structures.
- Evident from the text: it is a narrative/opinion-style argument without systematic review methods or new data, and its conclusions rely on selected cited studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 A few examples highlight the huge heterogeneity of chemical structures of PFAS, which poses challenges for their regulation. The physical and chemical properties of PFASs vary widely depending on their chain length, branching, and functional groups. These properties affect their environmental fate and transport, bioaccumulation potential, and toxicity. The bonds between the atoms are represented by lines. CAS, Chemical Abstracts Service Registry Number, is a numeric identifier assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS). (A) Perfluorooctanoic acid (PFOA), CAS: 335-67-1; (B) perfluorooctanesulfonic acid (PFOS), CAS: 1763-23-1; (C) perfluorononanoic acid (PFNA), CAS: 375-95-1; (D) perfluorohexanesulfonic acid (PFHxS), CAS: 355-46-4; (E) perfluorodecanoic acid (PFDA), CAS: 335-76-2; (F) 2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid (GenX or HFPO-DA), CAS: 13252-13-6; (G) 2,2-difluoro-2-{[2,2,4,5-tetrafluoro-5-(trifluoromethoxy)-1,3-dioxolan-4-yl]oxy}acetic acid (C6O4), CAS: 682-238-0; (H) P,P-Bis(perfluoro-7-methyloctyl) phosphinothioic acid erbium(3+) salt (3:1), CAS: 500776-89-6; (I) perfluorodecalin, CAS: 306-94-5; (J) perfluorotripropylamine, CAS: 338-83-0; (K) perfluoro-2,3-dimethylbutane, CAS: 354-96-1; (L) perfluoroperhydrophenanthrene, CAS: 306-91-2; (M) perfluoro-(2,5,8-trimethyl-3,6,9-trioxadodecanoic)acid, CAS: 65294-16-8; (N) dotriacontafluorononakis(trifluoromethyl)nonaoxatriacontanoyl fluoride, CAS: 65150-88-1; (O) bis 18:2 fluorotelomer thioether.](https://figures.cochat.ai/paper-figures/8d4dcee09eb549e488c38f63813b1ab4/the-eus-per-and-polyfluoroalkyl-substances-pfas-ban-a-case-of-policy-over-figure-1.jpg)
Verification
Claims the paper makes
32 Valid · 6 Not valid · 29 Not checked · 31 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, fluoropolymers do not exhibit the toxicological and environmental properties commonly associated with other PFAS of concern [4].”
§ The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science > 1. Introduction
What the sources say
- Partly supportedcites [4] Ameduri, 2023, Fluoropolymers: A Special Class of per- and Polyfluoroalkyl Substances (PFASs) Essential for Our Daily Life, J. Fluor. Chem. sourceExperimental — accuracy not yet measured
The Conclusions (p. 8) describe fluoropolymers as non-toxic, non-bioaccumulative and non-mobile, supporting the comparison with other PFAS of concern. However, the discussion on p. 5 explicitly says fluoropolymers are persistent, so the claim is too broad if it includes that environmental property. (LLM, conf=0.85)
- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Indeed, a noticeable declining trend in PFAS serum concentrations has been observed among Swedish adolescents and Norwegian men and women [10,11].”
§ The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science > 1. Introduction
What the sources say
- Supportedcites [10] Lindh, 2021, Temporal Trends, 2000-2017, of Perfluoroalkyl Acid (PFAA) Concentrations in Serum of Swedish Adolescents, Environ. Int. source
The Conclusions report declining serum concentrations of PFOS, PFOA, and PFHxS in Swedish adolescents. The Norwegian population is covered by the other citation in the citing sentence, not attributed to this source. (LLM, conf=0.93)
- Supportedcites [11] Berg, 2021, Time Trends of Perfluoroalkyl Substances in Blood in 30-Year Old Norwegian Men and Women in the Period 1986–2007, Environ. Sci. Pollut. Res. Int. source
The Conclusions report decreased PFAS blood burdens in 30-year-old Norwegian men and women, supporting the portion of the jointly cited sentence about Norway. The Discussion specifies that several PFAS concentrations declined after 2000, although some longer-chain PFASs increased. This paper is not being relied on for the Swedish-adolescent portion. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In fact, for some PFAS, the only available values for physical and chemical properties are estimates derived from mathematical models, such as quantitative structure–activity relationship (QSAR) models [18], which can approximate the chemical and physical properties of compounds based on their chemical structure, rather values from direct measurements [19,20].”
§ The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science > 2. PFAS Are Not a Small Group of Chemicals with Similar Properties
What the sources say
- Not checked — no full text of the sourcecites [18] Polishchuk, 2017, Interpretation of Quantitative Structure-Activity Relationship Models: Past, Present, and Future, J. Chem. Inf. Model. source
- Partly supportedcites [19] Brusseau, 2021, The Influence of Molecular Structure on PFAS Adsorption at Air-Water Interfaces in Electrolyte Solutions, Chemosphere sourceExperimental — accuracy not yet measured
The Introduction (page not provided) says QSPR models estimate PFAS properties from molecular structure because measuring interfacial adsorption coefficients for thousands of PFAS is impractical. Materials and Methods (page not provided) also describes calculating molar volumes when densities were unavailable. The paper does not establish the broader claim that model estimates are the only available physical and chemical property values for some PFAS. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [20] Lampic, 2020, Property Estimation of Per- and Polyfluoroalkyl Substances: A Comparative Assessment of Estimation Methods, Environ. Toxicol. Chem. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“However, PPARα activators are unlikely to cause liver tumors in humans due to differences in biological response to PPARα activation in key downstream events [28,32,33].”
§ The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science > 3. Different Structures Mean Different Mechanisms of Action
What the sources say
- Not checked — no full text of the sourcecites [28] Elcombe, 2010, Hepatocellular Hypertrophy and Cell Proliferation in Sprague-Dawley Rats Following Dietary Exposure to Ammonium Perfluorooctanoate Occurs through Increased Activation of the Xenosensor Nuclear Receptors PPARα and CAR/PXR, Arch. Toxicol. source
- Supportedcites [32] Corton, 2018, The PPARα-Dependent Rodent Liver Tumor Response Is Not Relevant to Humans: Addressing Misconceptions, Arch. Toxicol. source
The Summary (page not provided) says that species more representative of humans show PPARα activation but lack downstream changes in cell growth, hepatocyte proliferation, and liver cancer. It concludes that the rodent liver-tumor mechanism is unlikely to be relevant to humans. (LLM, conf=0.95)
- Not matchedcites [33] IARC (1995). Peroxisome Proliferation and Its Role in Carcinogenesis, IARC.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent studies did not modify the limitation of using rodent parameters to establish TEFs that are intended to be used to estimate human health risks related to PFAS mixtures exposure.”
§ The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science > 4. The Lack of Scientific Basis for the Application of the Toxicity-Equivalent Factors to PFAS
What the sources say
- Not checked — no full text of the sourcecites [48] Bil, 2021, Risk Assessment of Per- and Polyfluoroalkyl Substance Mixtures: A Relative Potency Factor Approach, Environ. Toxicol. Chem. source
- Supportedcites [49] Bil, 2022, Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring, Environ. Health Perspect. source
The Introduction describes deriving potency factors from male-rat liver effects and applying them to human biomonitoring data. The Discussion says deriving comparable factors from human epidemiological data has not yet been shown feasible and calls for validation across other species and endpoints. The paper calls these factors RPFs rather than TEFs, but supports the claim that the human-risk method still relies on rodent data. (LLM, conf=0.88)
- Partly supportedcites [50] Bil, 2023, Internal Relative Potency Factors Based on Immunotoxicity for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring, Environ. Int. sourceExperimental — accuracy not yet measured
The Introduction says earlier PFAS potency factors were derived from rat liver effects for use with human biomonitoring data. The Conclusion reports that this study derived factors from rat immune measures, while its human epidemiological data could not yield reliable estimates. This supports the point that reliance on rodent data persisted, but the paper calls these factors RPFs, not TEFs, and does not explicitly characterize that reliance as a limitation. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
35 more claims · 5 with their cited sources checked
Create a free account to see all 98 claims and to verify the 2 references still open.
- Probably not a substantial claim. 23
- It may state two separate claims as one. 46
Citations
Cites
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Van den Berg, M., Birnbaum, L. S., Denison, M., De Vito, M., Farland, W., Feeley, M., Fiedler, H., Hakansson, H., Hanberg, A., Haws, L., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl055 · Cited by 3,785
The Association Between Income and Life Expectancy in the United States, 2001–2014
Chetty, R., Stepner, M., Abraham, S., Lin, S., Scuderi, B., Turner, N., Bergeron, A., & Cutler, D. (2016) · JAMA · doi:10.1001/jama.2016.4226 · Cited by 2,812
Modern Fluoroorganic Chemistry: Synthesis, Reactivity, Applications
Kirsch, P. (2013) · doi:10.1002/9783527651351 · Cited by 1,029
Tyagi, S., Gupta, P., Saini, A., Kaushal, C., & Sharma, S. (2011) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/2231-4040.90879 · Cited by 1,017
Risk to human health related to the presence of perfluoroalkyl substances in food
Panel), E. P. O. C. I. T. F. C. (. C., Schrenk, D., Bignami, M., Bodin, L., Chipman, J. K., del Mazo, J., Grasl‐Kraupp, B., Hogstrand, C., Hoogenboom, L. (., Leblanc, J., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.6223 · Cited by 989 · cited 1×
“9 ng/mL for PFOS and PFOA, respectively [39].”
BackgroundOral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.013 · Cited by 835
Fate and Effects of Poly- and Perfluoroalkyl Substances in the Aquatic Environment: A Review
Ahrens, L., & Bundschuh, M. (2014) · Environmental Toxicology and Chemistry · doi:10.1002/etc.2663 · Cited by 817 · cited 1×
“Compounds with longer carbon chains, such as PFOA and PFOS, are the most persistent in the environment and can accumulate in living organisms [26,58,59].”
BackgroundPPARs in Obesity-Induced T2DM, Dyslipidaemia and NAFLD
Gross, B., Pawlak, M., Lefebvre, P., & Staels, B. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.135 · Cited by 778
Li, F., Duan, J., Tian, S., Ji, H., Zhu, Y., Wei, Z., & Zhao, D. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.122506 · Cited by 707
A New OECD Definition for Per- and Polyfluoroalkyl Substances
Wang, Z., Buser, A. M., Cousins, I. T., Demattio, S., Drost, W., Johansson, O., Ohno, K., Patlewicz, G., Richard, A. M., Walker, G. W., et al. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c06896 · Cited by 581
Huang, S., & Jaffé, P. R. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b04047 · Cited by 524
Low-temperature mineralization of perfluorocarboxylic acids
Trang, B., Li, Y., Xue, X.-S., Ateia, M., Houk, K. N., & Dichtel, W. R. (2022) · Science · doi:10.1126/science.abm8868 · Cited by 425 · cited 2×
“Along with physicochemical techniques [27], bioremediation appears to be a successful solution for PFAS removal from the environment [73,74].”
BackgroundGlynn, A., Berger, U., Bignert, A., Ullah, S., Aune, M., Lignell, S., & Darnerud, P. O. (2012) · Environmental Science & Technology · doi:10.1021/es301168c · Cited by 417
Biodegradation of Per- and Polyfluoroalkyl Substances (PFAS): A Review
Zhang, Z., Sarkar, D., Biswas, J. K., & Datta, R. (2022) · Bioresource Technology · doi:10.1016/j.biortech.2021.126223 · Cited by 353 · cited 1×
“Along with physicochemical techniques [27], bioremediation appears to be a successful solution for PFAS removal from the environment [73,74].”
BackgroundXu, Y., Fletcher, T., Pineda, D., Lindh, C. H., Nilsson, C., Glynn, A., Vogs, C., Norström, K., Lilja, K., Jakobsson, K., et al. (2020) · Environmental Health Perspectives · doi:10.1289/ehp6785 · Cited by 342
Fluoropolymers in Biomedical Applications: State-of-the-Art and Future Perspectives
Lv, J., & Cheng, Y. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00258e · Cited by 316 · cited 1×
“This is particularly true for fluoropolymers and perfluoropolyether oils, which are used in a wide range of industries and applications, including the automotive, aerospace, chemical, and nuclear industries, and electronics, medical devices, and greeneconomy initiatives [7,8].”
BackgroundHow Big Is Too Big for Cell Permeability?
Matsson, P., & Kihlberg, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00237 · Cited by 303
Berhanu, A., Mutanda, I., Taolin, J., Qaria, M. A., Yang, B., & Zhu, D. (2023) · Science of The Total Environment · doi:10.1016/j.scitotenv.2022.160010 · Cited by 294 · cited 1×
“Several microbial enzymes, including esterases, hydrolases, oxidases, reductases, and dehalogenases, play key roles in PFAS biodegradation, and advances in enzyme engineering and biocatalysis offer the potential for the development of efficient and sustainable PFAS bioremediation strategies [77,78].”
BackgroundKotlarz, N., McCord, J., Collier, D., Lea, C. S., Strynar, M., Lindstrom, A. B., Wilkie, A. A., Islam, J. Y., Matney, K., Tarte, P., et al. (2020) · Environmental Health Perspectives · doi:10.1289/ehp6837 · Cited by 261
Cao, Y., & Ng, C. (2021) · Environmental Science: Processes & Impacts · doi:10.1039/d1em00228g · Cited by 250
Henry, B. J., Carlin, J. P., Hammerschmidt, J. A., Buck, R. C., Buxton, L. W., Fiedler, H., Seed, J., & Hernandez, O. (2018) · Integrated Environmental Assessment and Management · doi:10.1002/ieam.4035 · Cited by 249 · cited 1×
“In addition, the large size of fluoropolymers results in their lower solubility in water, further limiting their mobility and potential for dispersion in the environment [66,67].”
BackgroundInterpretation of Quantitative Structure-Activity Relationship Models: Past, Present, and Future
Polishchuk, P. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00274 · Cited by 236
Activation of Human Nuclear Receptors by Perfluoroalkylated Substances (PFAS)
Behr, A.-C., Plinsch, C., Braeuning, A., & Buhrke, T. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104700 · Cited by 235
Ojo, A. F., Peng, C., & Ng, J. C. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124863 · Cited by 221
Evans, N., Conley, J. M., Cardon, M., Hartig, P., Medlock-Kakaley, E., & Gray, L. E. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116136 · Cited by 208
Pizzurro, D. M., Seeley, M., Kerper, L. E., & Beck, B. D. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.05.008 · Cited by 206 · cited 2×
“In addition, the study highlighted the significant problems in extrapolating health effects from laboratory animals to humans in the context of PFAS exposure [42].”
BackgroundYang, C.-H., Glover, K. P., & Han, X. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq219 · Cited by 197 · cited 1×
“In humans, organic anion transporter 4 (OAT4) and urate transporter 1 (URAT1) play important roles in facilitating PFAS reuptake from the pre-urinary environment [43].”
BackgroundHouck, K. A., Patlewicz, G. Y., Richard, A. M., Williams, A. J., Shobair, M., Smeltz, M. G., Clifton, M. S., Wetmore, B. A., Medvedev, A. V., & Makarov, S. S. (2021) · Toxicology · doi:10.1016/j.tox.2021.152789 · Cited by 189
Recent Advances on PFAS Degradation via Thermal and Nonthermal Methods
Verma, S., Lee, T., Sahle-Demessie, E., Ateia, M., & Nadagouda, M. N. (2023) · Chemical Engineering Journal Advances · doi:10.1016/j.ceja.2022.100421 · Cited by 187
Lewis, A. J., Yun, X., Spooner, D. E., Kurz, M. J., McKenzie, E. R., & Sales, C. M. (2022) · Science of The Total Environment · doi:10.1016/j.scitotenv.2022.153561 · Cited by 184
The PPARα-Dependent Rodent Liver Tumor Response Is Not Relevant to Humans: Addressing Misconceptions
Corton, J. C., Peters, J. M., & Klaunig, J. E. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2094-7 · Cited by 175
Risk Assessment of Per- and Polyfluoroalkyl Substance Mixtures: A Relative Potency Factor Approach
Bil, W., Zeilmaker, M., Fragki, S., Lijzen, J., Verbruggen, E., & Bokkers, B. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4835 · Cited by 158 · cited 1×
“Indeed, a database of rat liver endpoints for 16 PFAS was established, allowing for relative potency factors (RPFs) calculations and risk assessment of mixture exposure [48].”
BackgroundYu, Y., Che, S., Ren, C., Jin, B., Tian, Z., Liu, J., & Men, Y. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.1c05509 · Cited by 143
Xu, B., Qiu, W., Du, J., Wan, Z., Zhou, J. L., Chen, H., Liu, R., Magnuson, J. T., & Zheng, C. (2022) · iScience · doi:10.1016/j.isci.2022.104061 · Cited by 138
Bjork, J. A., & Wallace, K. B. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp093 · Cited by 137
Yang, Q., Xie, Y., Alexson, S. E. H., Dean Nelson, B., & DePierre, J. W. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00923-1 · Cited by 131 · cited 1×
“These findings highlight the significant role of PPARα in the immunomodulation induced by PFOA and other peroxisome proliferators [37].”
BackgroundGreaves, A. K., Letcher, R. J., Sonne, C., Dietz, R., & Born, E. W. (2012) · Environmental Science & Technology · doi:10.1021/es303400f · Cited by 127 · cited 1×
“PFCAs and PFSAs, but not all PFAS, exhibit high stability and their lipophilicity depends on the length of the alkylic chain, resulting in their accumulation in several tissues [56].”
BackgroundGoodrum, P. E., Anderson, J. K., Luz, A. L., & Ansell, G. K. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfaa123 · Cited by 118
Engineering Biocatalytic Material for the Remediation of Pollutants: A Comprehensive Review
Mishra, B., Varjani, S., Agrawal, D. C., Mandal, S. K., Ngo, H. H., Taherzadeh, M. J., Chang, J.-S., You, S., & Guo, W. (2020) · Environmental Technology & Innovation · doi:10.1016/j.eti.2020.101063 · Cited by 118
Feng, X., Chen, X., Yang, Y., Yang, L., Zhu, Y., Shan, G., Zhu, L., & Zhang, S. (2021) · Environment International · doi:10.1016/j.envint.2021.106824 · Cited by 109
Elcombe, C. R., Elcombe, B. M., Foster, J. R., Farrar, D. G., Jung, R., Chang, S.-C., Kennedy, G. L., & Butenhoff, J. L. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0572-2 · Cited by 96
Korzeniowski, S. H., Buck, R. C., Newkold, R. M., kassmi, A. E., Laganis, E., Matsuoka, Y., Dinelli, B., Beauchet, S., Adamsky, F., Weilandt, K., et al. (2023) · Integrated Environmental Assessment and Management · doi:10.1002/ieam.4646 · Cited by 93 · cited 3×
“In addition, the large size of fluoropolymers results in their lower solubility in water, further limiting their mobility and potential for dispersion in the environment [66,67].”
BackgroundBrusseau, M. L., & Van Glubt, S. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.130829 · Cited by 86
Gomis, M. I., Vestergren, R., MacLeod, M., Mueller, J. F., & Cousins, I. T. (2017) · Environment International · doi:10.1016/j.envint.2017.08.002 · Cited by 85
Louisse, J., Dellafiora, L., van den Heuvel, J. J. M. W., Rijkers, D., Leenders, L., Dorne, J.-L. C. M., Punt, A., Russel, F. G. M., & Koenderink, J. B. (2023) · Archives of Toxicology · doi:10.1007/s00204-022-03428-6 · Cited by 84
Frigerio, G., Cafagna, S., Polledri, E., Mercadante, R., & Fustinoni, S. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03762-1 · Cited by 80 · cited 1×
“Consequently, active efforts are currently underway to establish suitable methodologies for the detection of these alternative PFAS compounds within human blood [12].”
BackgroundNorén, E., Lindh, C., Glynn, A., Rylander, L., Pineda, D., & Nielsen, C. (2021) · Environment International · doi:10.1016/j.envint.2021.106716 · Cited by 75
Relevance of the Aryl Hydrocarbon Receptor (AhR) for Clinical Toxicology
Bradshaw, T. D., & Bell, D. R. (2009) · Clinical Toxicology · doi:10.1080/15563650903140423 · Cited by 62
Nakamura, T., Ito, Y., Yanagiba, Y., Ramdhan, D. H., Kono, Y., Naito, H., Hayashi, Y., Li, Y., Aoyama, T., Gonzalez, F. J., et al. (2009) · Toxicology · doi:10.1016/j.tox.2009.09.004 · Cited by 57
Blood Oxygenation Using Fluoropolymer-Based Artificial Lung Membranes
Park, A., Song, Y., Yi, E., Duy Nguyen, B. T., Han, D., Sohn, E., Park, Y., Jung, J., Lee, Y. M., Cho, Y. H., et al. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01251 · Cited by 54
Liang, X., Yang, X., Jiao, W., Zhou, J., & Zhu, L. (2022) · Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156397 · Cited by 54
Lampic, A., & Parnis, J. M. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4681 · Cited by 52
Xing, Y., Li, Q., Chen, X., Huang, B., Ji, L., Zhang, Q., Fu, X., Li, T., & Wang, J. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06283 · Cited by 51
Bil, W., Ehrlich, V., Chen, G., Vandebriel, R., Zeilmaker, M., Luijten, M., Uhl, M., Marx-Stoelting, P., Halldorsson, T. I., & Bokkers, B. (2023) · Environment International · doi:10.1016/j.envint.2022.107727 · Cited by 51 · cited 1×
“Epidemiological data indicated inverse associations of the sum of PFOA, PFNA, PFHxS, and PFOS concentration with serum antibody concentration to mumps and rubella, but did not allow reliable RPFs estimation [50].”
BackgroundPetriello, M. C., Mottaleb, M. A., Serio, T. C., Balyan, B., Cave, M. C., Pavuk, M., Birnbaum, L. S., & Morris, A. J. (2022) · Environment International · doi:10.1016/j.envint.2021.106907 · Cited by 49
Cheng, W., Doering, J. A., LaLone, C., & Ng, C. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab004 · Cited by 49
Bioremediation of Perfluorochemicals: Current State and the Way Forward
Tang, K. H. D., & Kristanti, R. A. (2022) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-022-02694-z · Cited by 49 · cited 1×
“Several microbial enzymes, including esterases, hydrolases, oxidases, reductases, and dehalogenases, play key roles in PFAS biodegradation, and advances in enzyme engineering and biocatalysis offer the potential for the development of efficient and sustainable PFAS bioremediation strategies [77,78].”
BackgroundWhy Toxic Equivalency Factors Are Not Suitable for Perfluoroalkyl Chemicals
Peters, J. M., & Gonzalez, F. J. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200316x · Cited by 48
Bil, W., Zeilmaker, M. J., & Bokkers, B. G. H. (2022) · Environmental Health Perspectives · doi:10.1289/ehp10009 · Cited by 47 · cited 1×
“By applying dose–response modeling, these internal exposures are used to derive quantitative internal RPFs based on liver weight effects [49].”
MethodCousins, I. T., De Witt, J. C., Glüge, J., Goldenman, G., Herzke, D., Lohmann, R., Miller, M., Ng, C. A., Patton, S., Scheringer, M., et al. (2021) · Environmental Science: Processes & Impacts · doi:10.1039/d1em00180a · Cited by 45
Albrecht, P. P., Torsell, N. E., Krishnan, P., Ehresman, D. J., Frame, S. R., Chang, S.-C., Butenhoff, J. L., Kennedy, G. L., Gonzalez, F. J., & Peters, J. M. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs318 · Cited by 44
Ameduri, B. (2023) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2023.110117 · Cited by 43
Zhang, M., Yamada, K., Bourguet, S., Guelfo, J., & Suuberg, E. M. (2020) · Journal of Chemical & Engineering Data · doi:10.1021/acs.jced.9b00922 · Cited by 42 · cited 1×
“Available data suggest that both the melting temperature and melting enthalpy of PFAS increase with the length of the fluorinated carbon chain [20,21].”
BackgroundCrisalli, A. M., Cai, A., & Cho, B. P. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00011 · Cited by 40
Saito, M., Kondo, N., Oshio, T., Tabuchi, T., & Kondo, K. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16020182 · Cited by 36 · cited 1×
“A blanket ban on all substances could have serious economic, industrial, and environmental consequences, and, paradoxically, public health implications [5,6].”
BackgroundNakagawa, T., Ramdhan, D. H., Tanaka, N., Naito, H., Tamada, H., Ito, Y., Li, Y., Hayashi, Y., Yamagishi, N., Yanagiba, Y., et al. (2012) · Archives of Toxicology · doi:10.1007/s00204-011-0704-3 · Cited by 33 · cited 1×
“A study on APFO-induced liver injury shows different histopathologic manifestations, supporting the conclusion that APFO activates PPARα differently in mice and humans, potentially leading to different liver injury [29].”
BackgroundHsu, J.-Y., Hsu, J.-F., Ho, H.-H., Chiang, C.-F., & Liao, P.-C. (2013) · Chemosphere · doi:10.1016/j.chemosphere.2013.06.047 · Cited by 32
Berg, V., Sandanger, T. M., Hanssen, L., Rylander, C., & Nøst, T. H. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13809-6 · Cited by 29 · cited 1×
“Indeed, a noticeable declining trend in PFAS serum concentrations has been observed among Swedish adolescents and Norwegian men and women [10,11].”
BackgroundHouck, K. (2022) · ALTEX · doi:10.14573/altex.2203041 · Cited by 20 · cited 1×
“The activity profile of PFOA shares some common features with that of dexamethasone, but also shows unique characteristics [41].”
BackgroundSolid Vapor Pressure and Enthalpy of Sublimation for Ammonium Perfluorooctanoate
Barton, C. A., Botelho, M. A., & Kaiser, M. A. (2009) · Journal of Chemical & Engineering Data · doi:10.1021/je800418m · Cited by 18
Application of Perfluoropolyether Elastomers in Microfluidic Drug Metabolism Assays
Wang, M., Tsuda, M., Deguchi, S., Higuchi, Y., So, K., Torisawa, Y.-S., Takayama, K., & Yamashita, F. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122253 · Cited by 10
Schindler, B. J., Buchanan, J. H., Mahle, J. J., Peterson, G. W., & Glover, T. G. (2013) · Journal of Chemical & Engineering Data · doi:10.1021/je400205g · Cited by 9 · cited 1×
“Highly volatile compounds have a greater potential for long-range transport because they are easily converted to the gas phase and can travel long distances in the atmosphere, whereas chemicals with low vapor pressures are more likely to remain in the solid and liquid forms and are generally transported through the so…”
BackgroundColnot, T., & Dekant, W. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03336-9 · Cited by 9
Bruno, S., Bersani, M., Astore, S., Chiabotto, G., Barge, A., Binello, A., & Spyrakis, F. (2022) · Toxicology · doi:10.1016/j.tox.2022.153257 · Cited by 7 · cited 1×
“These results highlight the existence of different transport mechanisms for different PFAS, with these mechanisms potentially influencing their elimination and bioaccumulation in the body [45].”
BackgroundSelf-citation
Cited by
Future of plasma etching for microelectronics: Challenges and opportunities
Oehrlein, G. S., Brandstadter, S. M., Bruce, R. L., Chang, J. P., DeMott, J. C., Donnelly, V. M., Dussart, R., Fischer, A., Gottscho, R. A., Hamaguchi, S., et al. (2024) · Journal of Vacuum Science & Technology B · doi:10.1116/6.0003579 · Cited by 189
Ameduri, B. M. (2023) · Molecules · doi:10.3390/molecules28227564 · Cited by 100
Material Challenges Facing Scalable Dry-Processable Battery Electrodes
Kim, N.-Y., Kim, J., Koo, H., Oh, J., Pang, J.-H., Kang, K.-D., Chae, S.-S., Lim, J., Nam, K. W., & Lee, S. (2024) · ACS Energy Letters · doi:10.1021/acsenergylett.4c01690 · Cited by 73
Chen, Z., Hua, Z., & Guo, P. (2024) · Water Research · doi:10.1016/j.watres.2024.121878 · Cited by 66
Fluorine-Free Lithium Metal Batteries with a Stable LiF-Free Solid Electrolyte Interphase
Jiang, Z., Li, C., Yang, T., Deng, Y., Zou, J., Zhang, Q., & Li, Y. (2024) · ACS Energy Letters · doi:10.1021/acsenergylett.3c02724 · Cited by 57
Metadata
- Authors
- Spyrakis, F., & Dragani, T. A.
- Affiliations
- University of Turin (IT)
- Aspidia srl (Italy) (IT)
- Corresponding author
- Dragani, Tommaso A.
- Venue
- Toxics
- Publisher
- MDPI AG
- Published
- 2023-08-22
- Volume
- 11
- Issue
- 9
- Pages
- 721
- ISSN
- 2305-6304 (ISSN-L)
- PMC
- PMC10536631
- OpenAlex
- W4386070248
- Semantic Scholar
- dc4e99ecf75e05493f10b7139873ad27c9c00b06
- Cited by
- 78
- References
- 77
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 20 · 2023: 1
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Toxics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Aspidia srl (SPYF_RILO_22_1)
- University of Turin (SPYF_RILO_22_1)
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Physical Sciences › Materials Science › Polymers and Plastics › Synthesis and properties of polymers
- Physical Sciences › Chemistry › Organic Chemistry › Fluorine in Organic Chemistry
- Keywords
- per- and polyfluoroalkyl substances, European Chemicals Agency, chemical policy, fluorinated polymers, biopersistence, bioaccumulation, toxicity prediction, greenhouse gas emissions, energy efficiency, medical devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.